SpinalCyte’s CybroCell Dermal Fibroblasts signals positive Phase 1/2 Clinical Trial Results Read more
Bavarian Nordic announces positive results of Pivotal Phase 3 Study of IMVAMUNE smallpox vaccine Read more
Xcovery initiates Phase 2 Clinical Trial for Ensartinib in Melanoma Patients with ALK Alternations Read more